I-Corps: A device to improve the ability to monitor the fetus and uterus during pregnancy, labor, and delivery

I-Corps项目的更广泛影响/商业潜力是开发一种新的胎儿监测器，以准确评估以前剖腹产（手术）分娩的妇女的胎儿健康和子宫疤痕的完整性。美国每年大约有400万新生儿。胎儿监护市场预计到2022年将达到约36亿美元。该项目将推进监测仪器的翻译工作，提供准确的数据，改善产妇的流动性，改善结果。此外，预计该技术是一次性的，可减少接触病原体传播的机会——这在大流行期间尤其有益。这个I-Corps项目推进了一种医疗设备的翻译，该设备可以在怀孕、分娩和分娩期间监测胎儿和子宫。今天的胎儿监护仪在提供胎儿在子宫内健康状况的一致解释数据方面是不可靠的，需要不断调整以确保胎儿的一致追踪。这个过程很麻烦，而且会带来危险的错误，最常见的原因是胎儿、母体和监护仪的移动。这一过程探索了一种无线设备，以一致、彻底、卫生和有效的方式产生有价值的监测数据，这对患者来说是舒适的。该奖项反映了美国国家科学基金会的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

The broader impact/commercial potential of this I-Corps project is the development of a new fetal monitor to accurately assess fetal health and the integrity of the uterine scar in the case where a woman has a previous C-section (operative) delivery. There are about 4 million births in the US annually. The fetal monitoring market is expected to reach approximately $3.6 billion in 2022. This project will advance translation of a monitor providing accurate data, improved maternal mobility, and better outcomes. Furthermore, the technology is envisioned to be disposable, reducing exposure to pathogen transmission - a benefit in particular during the pandemic.This I-Corps project advances translation of a medical device that monitors the fetus and uterus during pregnancy, labor and delivery. Fetal monitors today are unreliable at providing consistent interpretive data of fetal well-being in utero and require constant readjustment to ensure consistent fetal tracing. This process is cumbersome and introduces dangerous errors, most often due to fetal, maternal and monitor movement. This process explores a wireless device generating valuable monitoring data in a consistent, thorough, hygienic, and efficient manner that is comfortable for the patient.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.